Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
Abstract DNA damage activates cell cycle checkpoint proteins ATR and CHK1 to arrest cell cycle progression, providing time for repair and recovery. Consequently, inhibitors of ATR (ATRi) and CHK1 (CHK1i) enhance damage-induced cell death. Intriguingly, both CHK1i and ATRi alone elicit cytotoxicity i...
Guardado en:
Autores principales: | Jennifer P. Ditano, Katelyn L. Donahue, Laura J. Tafe, Charlotte F. McCleery, Alan Eastman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5351eae2b961433688e264c109fd09cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
por: Anna Di Benedetto, et al.
Publicado: (2017) -
Roles of nibrin and ATM/ATR kinases on the G2 checkpoint under endogenous or radio-induced DNA damage
por: Marcelain,Katherine, et al.
Publicado: (2005) -
The cytosolic iron–sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitors
por: Abena B. Redwood, et al.
Publicado: (2021) -
The Rad53CHK1/CHK2-Spt21NPAT and Tel1ATM axes couple glucose tolerance to histone dosage and subtelomeric silencing
por: Christopher Bruhn, et al.
Publicado: (2020) -
Critical role of SMG7 in activation of the ATR-CHK1 axis in response to genotoxic stress
por: Kathleen Ho, et al.
Publicado: (2021)